Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

Hofseth Biocare ASA: HBC ANNUAL REPORT 2021

25 Mar 2022 16:48 CET

Today, 25 March 2022, the Board of Directors of Hofseth BioCare ASA approved the
Annual Report for 2021.

Please find the Annual Report 2021 and ESG Report attached.

For further information, please contact:
Jon Olav Ødegård, CFO of Hofseth BioCare ASA
Phone: +47 93632966
E-mail: [email protected] (mailto:[email protected])

About Hofseth BioCare ASA

HBC is a Norwegian consumer and pet health ingredient supplier and an incubator
for new drug leads. Research is ongoing to identify the individual elements
within its ingredients that modulate inflammation and the immune response with
pre-clinical studies in multiple clinics and university research labs in several
countries. Lead clinical and pre-clinical candidates are focused on developing
an oral pharmaceutical lead program to treat inflammatory disease driven by
eosinophils. Preclinical trial work with the oil is ongoing to ameliorate lung
inflammation in eosinophilic asthma and COPD ("smokers lung") as well as
clinical work in COVID. Other leads are focused on the protection of the Gastro-
Intestinal (GI) system against inflammation (including ulcerative colitis and
the orphan condition necrotising enterocolitis) and using peptide fractions of
salmon protein hydrolysate (SPH also known as 'ProGo') as a Medical Food to help
treat age- related Sarcopenia, and as a treatment for Iron Deficiency Anemia.

The company is founded on the core values of sustainability, optimal utilization
of natural resources and full traceability. Through an innovative hydrolysis
technology, HBC can preserve the quality of lipids, proteins and calcium from
fresh salmon off-cuts.

Hofseth BioCare's headquarters are in Ålesund, Norway with branches in Oslo,
London, Zürich, New Jersey, and Palo Alto.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act

More information:
Access the news on Oslo Bors NewsWeb site

557688_HBC ESG Report 2021.pdf
557688_HBC Annual Report 2021 ENG.pdf
557688_hofsethbiocareasa-2021-12-31-no.zip

Source

Hofseth BioCare ASA

Provider

Oslo Børs Newspoint